Niraja Ranadive
Manipal University
5 Papers
4 Citations
Niraja Ranadive is an academic researcher from Manipal University. The author has contributed to research in topics: Cancer & Cognitive decline. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
An overview on chemotherapy-induced cognitive impairment and potential role of antidepressants
TL;DR: Antidepressants can have a beneficial effect on chemotherapy-induced inflammation and cognitive dysfunction via cytokine balance and neurogenesis property of certain antidepressant drugs rationalises their evaluation against CICI.
44
In vitro Cytotoxicity Activity of Chrysin, Morin and Resveratrol Against MCF-7 Breast Cancer Cell Lines
Arlene Thomas,Niraja Ranadive,Harisha Nayak,Sneha Surendran,Madhavan Nampoothiri,Jayesh Mudgal,Yogendra Nayak +6 more
TL;DR: Tests on the breast cancer cell lines were performed to provide with more novel drug treatments for breast cancer and Cytotoxic activity of flavonoids which includes morin and chrysin, and resveratrol, a natural polyphenol was checked individually on MCF7 breast cancers cell lines through MTT assay and the data was analyzed which could lead to new novel breast cancer treatments.
6
Sirtuins, a potential target in Traumatic Brain Injury and relevant experimental models
TL;DR: In this paper, the relevance of SIRTUINS as a potential pharmacological target in Traumatic Brain Injury (TBI) is discussed. And the experimental animal model of TBI explored to understand the role of SIRTs in TBI have been discussed.
Neuroprotective effect of Mulmina™ against chemotherapy-induced cognitive decline in normal rats
Manas Kinra,Niraja Ranadive,Karthik Gourishetti,Pawan G. Nayak,Rajesh N. Jagdale,Syed Mushtaq Ahmed,Kaggundi V. Raghavendra,Jayesh Mudgal,Krishnadas Nandakumar +8 more
TL;DR: The particular combination of phytochemicals in MulminA™ proved themselves successful in alleviating the CICD in this preliminary study and pave a path for future studies which can establish the solid grounds with respect to molecular and pharmacological basis for the mechanism of action of Mulmina™.